GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Omni Health OMHE · USD

N/A · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

At a glance

Figures in USD, from our data supplier.

FY2017

Revenue

$4.7m

FY2014FY2017

Net income

$1.3m

FY2014FY2017

Free cash flow

−$355,551

FY2014FY2017

Shareholders' equity

$3.6m

FY2014FY2017

Income statement

Fiscal years

FY2017FY2016FY2015FY2014
Revenue$4.7m$213,686$376,001$11,100
Gross profit$2.0m$28,968$169,467$2,600
Operating income$405,517−$534,032−$33,720−$6,400
Net income$1.3m−$534,032−$33,720−$6,400
Diluted earnings per share—-0.00-0.00—

Balance sheet

At each fiscal year end

FY2017FY2016FY2015FY2014
Total assets$5.5m$58,084$100,899$81,000
Cash and short-term investments———$3,500
Total liabilities$1.9m$190,258$140,464$86,900
Debt$1.4m———
Shareholders' equity$3.6m−$132,174−$39,565−$5,900
Shares outstanding—516m500m500m

Cash flow

Fiscal years

FY2017FY2016FY2015FY2014
Cash from operations−$42,491−$575,099−$18,456−$10,400
Capital spending−$313,060−$313,060−$313,060—
Free cash flow−$355,551−$888,159−$331,516−$10,400

Latest quarters

By quarter end

Oct 2017Jul 2017Apr 2017Jan 2017Oct 2016Jul 2016Apr 2016Jan 2016
Revenue$546,332$900,021$1.4m$1.5m$1.3m$514,448$95,800$39,110
Gross profit−$480,716$41,620$1.0m$398,143$380,811$125,572−$3,300$1,637
Operating income−$1.7m−$392,237$427,659−$49,503$35,467−$24,105−$423,400−$24,040
Net income−$1.8m−$443,156$350,159−$90,349−$38,305$1.0m−$423,400−$24,040
Diluted earnings per share———-0.00-0.00-0.00-0.00-0.00
Total assets$5.2m$5.4m$5.5m$5.0m$5.0m$5.0m$58,100$95,400
Cash and short-term investments——————$21,800$51,000
Debt$2.0m$1.7m$1.4m—————
Shareholders' equity$2.3m$3.1m$3.6m$3.2m$3.3m$3.2m−$132,200−$93,100

Growth per year

Compound annual rate

3 years5 years10 years
Revenue650.7%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin40.3%40.6%——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return200%0%100%100%46919%23931%-26%-93%48%206%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.